Takahashi I - Search Results

1

Strategies for mucosal vaccine development.

Boyaka PN, Marinaro M, Vancott JL, Takahashi I, Fujihashi K, Yamamoto M, van Ginkel FW, Jackson RJ, Kiyono H, McGhee JR. Boyaka PN, et al. Among authors: takahashi i. Am J Trop Med Hyg. 1999 Apr;60(4 Suppl):35-45. doi: 10.4269/ajtmh.1999.60.35. Am J Trop Med Hyg. 1999. PMID: 10344675 Review.

2

Mucosal immunity to infection with implications for vaccine development.

Staats HF, Jackson RJ, Marinaro M, Takahashi I, Kiyono H, McGhee JR. Staats HF, et al. Among authors: takahashi i. Curr Opin Immunol. 1994 Aug;6(4):572-83. doi: 10.1016/0952-7915(94)90144-9. Curr Opin Immunol. 1994. PMID: 7946045 Review.

3

Oral vaccine models: multiple delivery systems employing tetanus toxoid.

Jackson RJ, Staats HF, Xu-Amano J, Takahashi I, Kiyono H, Hudson ME, Gilley RM, Chatfield SN, McGhee JR. Jackson RJ, et al. Among authors: takahashi i. Ann N Y Acad Sci. 1994 Aug 15;730:217-34. doi: 10.1111/j.1749-6632.1994.tb44251.x. Ann N Y Acad Sci. 1994. PMID: 8080173

4

Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccine.

Takahashi I, Kiyono H, Jackson RJ, Fujihashi K, Staats HF, Hamada S, Clements JD, Bost KL, McGhee JR. Takahashi I, et al. Infect Immun. 1996 Apr;64(4):1290-8. doi: 10.1128/iai.64.4.1290-1298.1996. Infect Immun. 1996. PMID: 8606092 Free PMC article.

5

Mechanisms for mucosal immunogenicity and adjuvancy of Escherichia coli labile enterotoxin.

Takahashi I, Marinaro M, Kiyono H, Jackson RJ, Nakagawa I, Fujihashi K, Hamada S, Clements JD, Bost KL, McGhee JR. Takahashi I, et al. J Infect Dis. 1996 Mar;173(3):627-35. doi: 10.1093/infdis/173.3.627. J Infect Dis. 1996. PMID: 8627026

6

gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses.

Fujihashi K, McGhee JR, Kweon MN, Cooper MD, Tonegawa S, Takahashi I, Hiroi T, Mestecky J, Kiyono H. Fujihashi K, et al. Among authors: takahashi i. J Exp Med. 1996 Apr 1;183(4):1929-35. doi: 10.1084/jem.183.4.1929. J Exp Med. 1996. PMID: 8666951 Free PMC article.

7

Mucosal immune network in the gut for the control of infectious diseases.

Iijima H, Takahashi I, Kiyono H. Iijima H, et al. Among authors: takahashi i. Rev Med Virol. 2001 Mar-Apr;11(2):117-33. doi: 10.1002/rmv.307. Rev Med Virol. 2001. PMID: 11262530 Review.

8

Mucosal T cells induce systemic anergy for oral tolerance.

Takahashi I, Nakagawa I, Kiyono H, McGhee JR, Clements JD, Hamada S. Takahashi I, et al. Biochem Biophys Res Commun. 1995 Jan 5;206(1):414-20. doi: 10.1006/bbrc.1995.1057. Biochem Biophys Res Commun. 1995. PMID: 7818546

9

Oral immunization with the B subunit of the heat-labile enterotoxin of Escherichia coli induces early Th1 and late Th2 cytokine expression in Peyer's patches.

Nakagawa I, Takahashi I, Kiyono H, McGhee JR, Hamada S. Nakagawa I, et al. Among authors: takahashi i. J Infect Dis. 1996 Jun;173(6):1428-36. doi: 10.1093/infdis/173.6.1428. J Infect Dis. 1996. PMID: 8648216

10

The mucosal immune system: from specialized immune defense to inflammation and allergy.

Kiyono H, Kweon MN, Hiroi T, Takahashi I. Kiyono H, et al. Among authors: takahashi i. Acta Odontol Scand. 2001 Jun;59(3):145-53. doi: 10.1080/000163501750266738. Acta Odontol Scand. 2001. PMID: 11501883 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,347 results

Search Page

Filters